These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32058)

  • 1. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
    Chiu S; Paulose CS; Mishra RK
    Peptides; 1981; 2(1):105-11. PubMed ID: 6113579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
    Costain WJ; Buckley AT; Evans MC; Mishra RK; Johnson RL
    Peptides; 1999; 20(6):761-7. PubMed ID: 10477133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
    Hatta K; Wolterink G; Van Ree JM
    Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasopressin release by D-aspartic acid, morphine and prolyl-leucyl-glycinamide (PLG) in DI Brattleboro rats.
    Koyuncuoğlu H; Berkman K; Hatipoğlu I; Sabuncu H
    Pharmacol Biochem Behav; 1984 Apr; 20(4):519-25. PubMed ID: 6145163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of morphine-induced tolerance and physical dependence by prolyl-leucyl-glycinamide.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1981 May; 71(2-3):259-68. PubMed ID: 6113968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease.
    Case TC; Snider SR; Hruby VJ; Rockway T
    Life Sci; 1985 Jul; 36(26):2531-7. PubMed ID: 2861549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of PLG (L-prolyl-L-leucyl-glycinamide) in treating Parkinson's disease].
    Pan JB
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):205-8. PubMed ID: 2866940
    [No Abstract]   [Full Text] [Related]  

  • 12. Endocrine influences on the actions of morphine. III. Responses to hypothalamic hormones.
    Kasson BG; George R
    Neuroendocrinology; 1983 Dec; 37(6):416-20. PubMed ID: 6140650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat.
    Bhargava HN
    Neuropharmacology; 1981 Apr; 20(4):385-90. PubMed ID: 6117032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.